Citalopram Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
Condition:   Major Depressive Disorder Interventions:   Drug: Placebo;   Device: intermittent theta burst stimulation;   Drug: intravenous citalopram hydrochloride (CIT);   Device: continuous theta burst stimulation Sponsor:   University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2021 Category: Research Source Type: clinical trials